Notice of Intent to Sole Source - Standards Development for Regenerative Medicine Therapies
Closed Special Notice Posted
A later notice was posted: the Limited / Sole Source Justification from .
- Solicitation number
- FDA-INT-1224405
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- B599 Special Studies/Analysis- Other
- Place of performance
- Silver Spring MD 20993 USA
Notice details come from SAM.gov. Updated .
Notice text
Notice of Intent to Sole Source - Standards Development for Regenerative Medicine Therapies per the attached FDA-INT-1224405_Final document.
Files
| File | Type | Posted |
|---|---|---|
| FDA-INT-1224405_Final.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| JA - Standards Development for Regenerative Medicine Therapies | Limited / Sole Source Justification | |
| This notice | Special Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity